The FDA revoked Johnson and Johnson’s emergency US authorization for the COVID vaccine.

Sharing is Caring!

The Food and Drug Administration (FDA) announced it had revoked the emergency use authorization (EUA) of the COVID-19 Vaccine Janssen.

On May 22, Janssen Biotech, a unit of US healthcare giant Johnson & Johnson, requested the voluntary withdrawal of the EUA for this vaccine, the FDA noted.

www.thepharmaletter.com/in-brief/brief-fda-revokes-eua-for-covid-19-vaccine-janssen
www.fda.gov/vaccines-blood-biologics/coronavirus-covid-19-cber-regulated-biologics/janssen-covid-19-vaccine

See also  FDA approves clinical trials for new “pandemic” vaccine. H5N1 vaccine

Views: 131

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.